Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2017-11-07 22:36:32 UTC |
---|
Update Date | 2022-03-07 03:18:13 UTC |
---|
HMDB ID | HMDB0240214 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Ponatinib |
---|
Description | Ponatinib, also known as ap 24534, belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. In humans, ponatinib is involved in the ponatinib inhibition of bcr-abl pathway. Ponatinib is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Ponatinib. |
---|
Structure | CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1 InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39) |
---|
Synonyms | Value | Source |
---|
AP 24534 | ChEBI | AP24534 | ChEBI | Ponatinibum | ChEBI | Iclusig | MeSH, HMDB | 3-(2-(imidazo(1,2-b)Pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-y-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide | MeSH, HMDB | Ponatinib hydrochloride | MeSH, HMDB |
|
---|
Chemical Formula | C29H27F3N6O |
---|
Average Molecular Weight | 532.5595 |
---|
Monoisotopic Molecular Weight | 532.219844131 |
---|
IUPAC Name | 3-(2-{imidazo[1,2-b]pyridazin-3-yl}ethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide |
---|
Traditional Name | ponatinib |
---|
CAS Registry Number | 943319-70-8 |
---|
SMILES | CN1CCN(CC2=CC=C(NC(=O)C3=CC(C#CC4=CN=C5C=CC=NN45)=C(C)C=C3)C=C2C(F)(F)F)CC1 |
---|
InChI Identifier | InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39) |
---|
InChI Key | PHXJVRSECIGDHY-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Anilides |
---|
Direct Parent | Benzanilides |
---|
Alternative Parents | |
---|
Substituents | - Benzanilide
- Trifluoromethylbenzene
- Benzamide
- Benzoic acid or derivatives
- P-toluamide
- Toluamide
- Benzoyl
- Benzylamine
- Phenylmethylamine
- Toluene
- N-methylpiperazine
- Aralkylamine
- N-alkylpiperazine
- 1,4-diazinane
- N-substituted imidazole
- Piperazine
- Pyridazine
- Heteroaromatic compound
- Azole
- Imidazole
- Tertiary amine
- Secondary carboxylic acid amide
- Amino acid or derivatives
- Tertiary aliphatic amine
- Carboxamide group
- Organoheterocyclic compound
- Azacycle
- Carboxylic acid derivative
- Amine
- Alkyl fluoride
- Alkyl halide
- Organohalogen compound
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organofluoride
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | Not Available |
---|
Process | |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ponatinib,1TMS,isomer #1 | CC1=CC=C(C(=O)N(C2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)[Si](C)(C)C)C=C1C#CC1=CN=C2C=CC=NN12 | 4182.0 | Semi standard non polar | 33892256 | Ponatinib,1TMS,isomer #1 | CC1=CC=C(C(=O)N(C2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)[Si](C)(C)C)C=C1C#CC1=CN=C2C=CC=NN12 | 3461.3 | Standard non polar | 33892256 | Ponatinib,1TMS,isomer #1 | CC1=CC=C(C(=O)N(C2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)[Si](C)(C)C)C=C1C#CC1=CN=C2C=CC=NN12 | 5007.5 | Standard polar | 33892256 | Ponatinib,1TBDMS,isomer #1 | CC1=CC=C(C(=O)N(C2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)[Si](C)(C)C(C)(C)C)C=C1C#CC1=CN=C2C=CC=NN12 | 4361.8 | Semi standard non polar | 33892256 | Ponatinib,1TBDMS,isomer #1 | CC1=CC=C(C(=O)N(C2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)[Si](C)(C)C(C)(C)C)C=C1C#CC1=CN=C2C=CC=NN12 | 3653.8 | Standard non polar | 33892256 | Ponatinib,1TBDMS,isomer #1 | CC1=CC=C(C(=O)N(C2=CC=C(CN3CCN(C)CC3)C(C(F)(F)F)=C2)[Si](C)(C)C(C)(C)C)C=C1C#CC1=CN=C2C=CC=NN12 | 5034.8 | Standard polar | 33892256 |
|
---|
| MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Ponatinib , positive-QTOF | splash10-014i-1490100000-181c36e7111f139a09cd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ponatinib , positive-QTOF | splash10-03e9-0290150000-ab2ecf1ddb48e116ad86 | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 10V, Positive-QTOF | splash10-001i-0050390000-64038b46e41e719fda3b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 20V, Positive-QTOF | splash10-03e9-0091410000-d3d39f28b2e30f41d8da | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 40V, Positive-QTOF | splash10-03e9-3190000000-e9fd592a159c87f87d2b | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 10V, Negative-QTOF | splash10-001i-1010090000-78898b8c1027002694b9 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 20V, Negative-QTOF | splash10-0f8a-3050090000-407a5960c1ec9fad0f8a | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 40V, Negative-QTOF | splash10-000x-9130010000-13ad74ef9521c4e5779e | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 10V, Negative-QTOF | splash10-001i-0000090000-92da9af4049b50a09456 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 20V, Negative-QTOF | splash10-001i-0120490000-ade5b8432aa91f8c8a04 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 40V, Negative-QTOF | splash10-0udi-1010790000-1fdb94844e659503a7da | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 10V, Positive-QTOF | splash10-001i-0000090000-32da3e42aa87b6da8663 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 20V, Positive-QTOF | splash10-0gx1-9870270000-1d13956b46e1e365c347 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ponatinib 40V, Positive-QTOF | splash10-01si-2192820000-e8c3f9dc0f96eb68b48e | 2021-09-24 | Wishart Lab | View Spectrum |
|
---|